TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strengthMartina Spiga, Stefano Beretta, Barbara Camisa et al.|Nature Communications|2026Cited by 2
Abstract LB029: TIGIT deletion rescues the antitumor activity of low avidity T cells by increasing TCR signal strengthMartina Spiga, Chiara Bonini, Alessia Potenza et al.|Cancer Research|2025Cited by 0